Retrospective Study
Copyright ©The Author(s) 2017.
World J Hepatol. Jan 8, 2017; 9(1): 57-63
Published online Jan 8, 2017. doi: 10.4254/wjh.v9.i1.57
Figure 1
Figure 1 Remission rate of each subgroup with ursodeoxycholic acid therapy. Remission was induced and maintained by ursodeoxycholic acid in 85%, 83% and 92% of patients in Subgroups A, B and C, respectively. On the other hand, the rates of remission induction and successful maintenance in Subgroups D, E, and F are low, at 40%, 53% and 50%, respectively. ALT: Alanine aminotransferase.